Name | Human G-CSF Quantikine PharmPak (50 Plates) |
---|---|
Supplier | R&D Systems |
Catalog | PDCS50 |
Category | ELISA Kit |
Assay Type | Solid Phase Sandwich ELISA |
Sample Type | Cell Culture Supernates (100 µL), Serum (100 µL), EDTA Plasma (100 µL), Heparin Plasma (100 µL), Citrate Plasma (100 µL) |
Sensitivity | 20 pg/mL |
Range | 39 - 2,500 pg/mL (Serum, Heparin Plasma, Cell Culture Supernates, Citrate Plasma, EDTA Plasma) |
Format | 96-well strip plate |
Description | The Quantikine Human G-CSF Immunoassay is a 3.5 or 4.5 hour solid phase ELISA designed to measure G-CSF in cell culture supernates, serum, and plasma |
Gene | CSF3 |
Supplier Page | Shop |
Kumar J, Fraser FW, Riley C, Ahmed N, McCulloch DR, Ward AC. Br J Cancer. 2014 Jan 7;110(1):133-45.
Robinson M, Li B, Ge Y, Ko D, Yendluri S, Harding T, VanRoey M, Spindler KR, Jooss K. J Virol. 2009 Apr;83(8):3450-62.
Makam M, Diaz D, Laval J, Gernez Y, Conrad CK, Dunn CE, Davies ZA, Moss RB, Herzenberg LA, Herzenberg LA, Tirouvanziam R. Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5779-83. doi:
Merlin E, Zohar S, Jerome C, Veyrat-Masson R, Marceau G, Paillard C, Auvrignon A, Le Moine P, Gandemer V, Sapin V, Halle P, Boiret-Dupre N, Chevret S, Demeocq F, Dubray C, Kanold J. Bone Marrow Transplant. 2009 Jun;43(12):919-25.
Sun Y, Yi D, Wang Y, Zheng R, Sun G, Wang J, Liu Y, Ren J, Wang Y, Zhang S, Gu C, Pei J. Cytokine. 2009 Sep;47(3):206-13.
Fox E, Widemann BC, Hawkins DS, Jayaprakash N, Dagher R, Aikin AA, Bernstein D, Long L, Mackall C, Helman L, Steinberg SM, Balis FM. Clin Cancer Res. 2009 Dec 1;15(23):7361-7.
Dower K, Ellis DK, Saraf K, Jelinsky SA, Lin LL. J Immunol. 2008 Mar 1;180(5):3520-34.
Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M. Exp Hematol. 2008 Aug;36(8):1035-46.
Rojahn A, Brusletto B, Ovstebo R, Haug KB, Kierulf P, Brandtzaeg P. Crit Care Med. 2008 Sep;36(9):2583-9.
Niederfuhr A, Kirsche H, Deutschle T, Poppert S, Riechelmann H, Wellinghausen N. Allergy. 2008 Oct;63(10):1359-67.